Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04169711
Title Study of ARO-HIF2 in Patients With Advanced Clear Cell Renal Cell Carcinoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Arrowhead Pharmaceuticals
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.